Update: FDA approval of Biogen's aducanumab

Geriatr Nurs. 2022 Jan-Feb:43:318-319. doi: 10.1016/j.gerinurse.2021.12.018. Epub 2022 Jan 5.

Author

Peter Hollmann¹

Affiliation

¹ President, American Geriatrics Society, United States. Electronic address: [email protected].

PMID: 34996638
DOI: 10.1016/j.gerinurse.2021.12.018

No abstract available

MeSH terms

Alzheimer Disease* / drug therapy
Antibodies, Monoclonal, Humanized* / therapeutic use
Drug Approval
Humans
United States
United States Food and Drug Administration

Substances

Antibodies, Monoclonal, Humanized
aducanumab